Prediction: U.S. Small-Cap Stocks Will Beat Large Caps for 10 Years

This is less a blanket endorsement of small caps than a factor rotation toward domestic, lower-multiple cash flows. The most attractive exposure is not the index itself but the subset that can actually refinance and grow without depending on repeated capital raises; that argues VBR over IWM on a risk-adjusted basis because the value tilt screens out more of the balance-sheet fragility. If the rotation persists, the marginal loser is megacap growth breadth: passive inflows and benchmark crowding can keep supporting NVDA and NFLX at an absolute level, but their relative multiple ceiling tightens as investors pay up for cheaper cyclicals and financials instead.

Second-order effects matter more than the headline. Small-cap leadership only sticks if credit stays cooperative; if lending standards tighten or spreads widen, the weakest names inside IWM can unwind fast even while the ETF looks fine on the surface. That makes CYTK the kind of stock that benefits only under stable risk appetite, while cash-generative value names inside VBR such as NRG and WSM should hold up better if the market is really paying for earnings quality and shareholder yield rather than pure duration.

Contrarian view: consensus may be extrapolating a year-to-date factor swing into a durable regime change before earnings revisions confirm it. Small caps need both lower real rates and a benign funding backdrop; if inflation re-accelerates or the Fed pushes cuts out, the trade can reverse sharply over days to weeks. For a 1-3 month window, the key falsifier is a renewed breakout in real yields or a widening in high-yield credit spreads; over 6-18 months, sustained small-cap outperformance requires broad-based EPS upgrades, not just multiple expansion.